03.06.19
San Francisco-based Gryphon Investors, a middle market private equity firm, has announced the acquisition of anti-aging skincare brand RoC, from Johnson & Johnson Consumer Inc.
Terms of the deal were not disclosed. RoC has a 60+ year history in anti-wrinkle and anti-aging skincare, with more than 75 products sold in the U.S., Europe, and Latin America. It was created in 1957 by French pharmacist Dr. Jean-Charles Lissarrague.
The transaction is Gryphon’s second investment in the beauty sector; the firm acquired Indie color cosmetics brand Milani Cosmetics in June 2018.
Late in 2018, J&J made an offer of $2.05 billion in cash to buy Japanese skincare company, Ci:z Holdings, which owns skincare brands Dr.Ci:Labo, Labo Labo, and Genomer. J&J already owns 19.9% of the company and is its second-largest shareholder.
More info: BeautyPackaging.com
Terms of the deal were not disclosed. RoC has a 60+ year history in anti-wrinkle and anti-aging skincare, with more than 75 products sold in the U.S., Europe, and Latin America. It was created in 1957 by French pharmacist Dr. Jean-Charles Lissarrague.
The transaction is Gryphon’s second investment in the beauty sector; the firm acquired Indie color cosmetics brand Milani Cosmetics in June 2018.
Late in 2018, J&J made an offer of $2.05 billion in cash to buy Japanese skincare company, Ci:z Holdings, which owns skincare brands Dr.Ci:Labo, Labo Labo, and Genomer. J&J already owns 19.9% of the company and is its second-largest shareholder.
More info: BeautyPackaging.com
